Agenus Inc (NASDAQ: AGEN) kicked off on Monday, down -3.89% from the previous trading day, before settling in for the closing price of $2.83. Over the past 52 weeks, AGEN has traded in a range of $2.50-$19.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 98.93% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 11.83%. With a float of $22.37 million, this company’s outstanding shares have now reached $23.46 million.
In an organization with 389 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 68.67%, operating margin of -61.67%, and the pretax margin is -145.41%.
Agenus Inc (AGEN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Agenus Inc is 4.65%, while institutional ownership is 33.66%. The most recent insider transaction that took place on Feb 15 ’24, was worth 324,050. In this transaction an insider of this company bought 500,000 shares at a rate of $0.65, taking the stock ownership to the 625,969 shares.
Agenus Inc (AGEN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 11.83% per share during the next fiscal year.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Take a look at Agenus Inc’s (AGEN) current performance indicators. Last quarter, stock had a quick ratio of 0.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.00, a number that is poised to hit -2.64 in the next quarter and is forecasted to reach -8.91 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.59 million. That was inferior than the volume of 0.64 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 12.91%. Additionally, its Average True Range was 0.30.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 5.46%, which indicates a significant decrease from 5.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.28% in the past 14 days, which was higher than the 86.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.62, while its 200-day Moving Average is $8.13. However, in the short run, Agenus Inc’s stock first resistance to watch stands at $2.84. Second resistance stands at $2.96. The third major resistance level sits at $3.03. If the price goes on to break the first support level at $2.64, it is likely to go to the next support level at $2.57. Assuming the price breaks the second support level, the third support level stands at $2.45.
Agenus Inc (NASDAQ: AGEN) Key Stats
The company with the Market Capitalisation of 65.43 million has total of 23,459K Shares Outstanding. Its annual sales at the moment are 156,310 K in contrast with the sum of -245,760 K annual income. Company’s last quarter sales were recorded 25,110 K and last quarter income was -66,390 K.
